EUVIMEDEUVIMED entdecken
Crossref

Non-HLA Antibodies and the Risk of Antibody-mediated Rejection without Donor-specific Anti-HLA Antibodies After Lung Transplantation

Alejandra Comins-Boo, Víctor Manuel Mora-Fernández, Paula Padrón-Aunceame, María Toriello-Suárez, Elena González-López, Adriel Roa-Bautista, Carolina Castro-Hernández, David Iturbe-Fernández, Manuel Cifrián José, Marco López-Hoyos, David San Segundo

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2024.11.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Alejandra Comins-Boo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain. Hauptthemen laut MEDLINE: Lung Transplantation, Graft Rejection, HLA Antigens, Isoantibodies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Carlos III Health Institute, Instituto de Investigación Marqués de Valdecilla, Marques de Valdecilla Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Antibody-mediated rejection (ABMR) has become one of the leading causes of chronic lung graft dysfunction. However, in lung transplantation, this entity is sometimes difficult and controversial to diagnose. It is mainly caused by the appearance of donor-specific anti-human leukocyte antigen (HLA) antibodies (DSA), although there are situations with C4d deposits in biopsy in the absence of circulating DSA. The aim of this work was to study the potential role of non-HLA antibodies in the development of ABMR without DSA after lung transplantation. METHODS: A case-control study was designed with a cohort of lung transplant recipients at our institution. Twenty-seven patients with ABMR and without anti-HLA antibodies were identified after lung transplantation, and a control group of 21 transplant recipients was selected with the same post-transplant follow-up without evidence of rejection. Non-HLA antibodies were studied pretransplant using Luminex (ThermoFisher, One Lambda). RESULTS: The median of the pretransplant non-HLA-positive antibodies in the group with ABMR without DSA is significantly higher than in the control group: 2 (interquartile range, 0-16) vs 0 (interquartile range, 0-1; P 1.5 pretransplant non-HLA antibodies were more likely to develop ABMR without DSA (sensitivity, 80.95%; specificity, 55.55%; area under the curve, 71.3%). CONCLUSION: The increase of non-HLA antibodies before lung transplantation has recently been shown to increase the risk of chronic lung allograft dysfunction. These results confirm that patients with a higher number of non-HLA antibodies could be at risk of developing ABMR without DSA. These results point out the possible usefulness of pre-lung transplant non-HLA antibodies to identify patients with end-stage lung disease at risk of developing ABMR without DSA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationGraft RejectionHLA AntigensIsoantibodiesHumansMaleFemaleCase-Control StudiesMiddle AgedAdultRisk FactorsTissue Donors

Substanzen

HLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.
  • Neumology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.
  • Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain. Electronic address: david.sansegundo@scsalud.es.

Förderung

  • Carlos III Health Institute
  • Instituto de Investigación Marqués de Valdecilla
  • Marques de Valdecilla Foundation

Zitieren

APA

Comins-Boo, A., Mora-Fernández, V. M., Padrón-Aunceame, P., Toriello-Suárez, M., González-López, E., Roa-Bautista, A., Castro-Hernández, C., Iturbe-Fernández, D., Cifrián José, M., López-Hoyos, M., & San Segundo, D. (2025). Non-HLA Antibodies and the Risk of Antibody-mediated Rejection without Donor-specific Anti-HLA Antibodies After Lung Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.11.031

Vancouver

Comins-Boo A, Mora-Fernández VM, Padrón-Aunceame P, Toriello-Suárez M, González-López E, Roa-Bautista A, et al. Non-HLA Antibodies and the Risk of Antibody-mediated Rejection without Donor-specific Anti-HLA Antibodies After Lung Transplantation. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2024.11.031

BibTeX
@article{CominsBoo2025,
  author = {Comins-Boo, Alejandra and Mora-Fernández, Víctor Manuel and Padrón-Aunceame, Paula and Toriello-Suárez, María and González-López, Elena and Roa-Bautista, Adriel and Castro-Hernández, Carolina and Iturbe-Fernández, David and Cifrián José, Manuel and López-Hoyos, Marco and San Segundo, David},
  title = {Non-HLA Antibodies and the Risk of Antibody-mediated Rejection without Donor-specific Anti-HLA Antibodies After Lung Transplantation},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2024.11.031}
}
Kostenlos starten →